MétaCan
Menu
Back to cohort
Record W3089086050 · doi:10.1136/jmedgenet-2020-107162

Globotriaosylsphingosine (lyso-Gb<sub>3</sub>) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort

2020· article· en· W3089086050 on OpenAlexaff
Grigoris Effraimidis, Ulla Feldt‐Rasmussen, Åse Krogh Rasmussen, Paméla Lavoie, Mona Abaoui, Michel Boutin, Christiane Auray‐Blais

Bibliographic record

VenueJournal of Medical Genetics · 2020
Typearticle
Languageen
FieldMedicine
TopicLysosomal Storage Disorders Research
Canadian institutionsUniversité de Sherbrooke
FundersNovo Nordisk Fonden
KeywordsLyso-UrineGlobotriaosylceramideInternal medicineFabry diseaseGenotypeMedicineChemistryUrologyEndocrinologyPharmacologyDiseasePhysicsBiochemistryGene

Abstract

fetched live from OpenAlex

Introduction Recent studies showed the usefulness of globotriaosylsphingosine (lyso-Gb 3 ) and related analogues, deacylated forms of globotriaosylceramide (Gb 3 ), for high-risk screening, treatment monitoring and follow-up for patients with Fabry disease. Methods We evaluated Gb 3 , lyso-Gb 3 and analogues using tandem mass spectrometry in 57 women with Fabry disease followed during a period of 15.4 years. Twenty-one women were never treated and 36 received treatment (agalsidase-beta, n=30; agalsidase-alfa, n=5; or migalastat, n=1). Lyso-Gb 3 and analogues at m/z (−28), (−2), (+16), (+34) and (+50) were analysed in plasma and urine. Total Gb 3 and lyso-Gb 3 analogues at m/z (−12) and (+14) were evaluated in urine while the analogue at m/z (+18) was evaluated in plasma. Results A strong correlation between plasma and urine lyso-Gb 3 and analogue levels was revealed. Plasma and urine lyso-Gb 3 and analogue levels were not statistically different between patients carrying missense (n=49), nonsense (n=6) or deletion mutations (n=2). Never treated patients had lower plasma lyso-Gb 3 and analogues at m/z (−28), (−2), (+16), (+34) and the seven urinary lyso-Gb 3 analogues compared with pretreatment levels of the treated patients. A significant reduction of plasma lyso-Gb 3 and five analogues, as well as urine Gb 3 and six lyso-Gb 3 analogues, but not lyso-Gb 3 and lyso-Gb 3 at m/z (+50), was observed post-treatment with agalsidase-beta. The same tendency was observed with agalsidase-alfa. Conclusion Women with Fabry disease who started treatment based on clinical manifestations had higher lyso-Gb 3 and analogue biomarker levels than never treated women. This indicates that a biomarker cut-off could potentially be a decision tool for treatment initiation in women with Fabry disease.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.013
Threshold uncertainty score0.356

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.267
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations19
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Medical GeneticsSame topicLysosomal Storage Disorders ResearchFrench-language works237,207